Neenv Ent And Cancer Hospitals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.30 M
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.79 Cr
- Revenue Growth 38.01%
- Profit Growth 4.32%
- Ebitda -14.24%
- Net Worth 29.51%
- Total Assets 21.88%
About Neenv Ent And Cancer Hospitals
Neenv Ent And Cancer Hospitals Private Limited (NEACHPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 July 2014 and has a history of Ten years and six months. Its registered office is in Jabalpur, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹1.79 Cr.
Nitin Adgaonkar and Akhil Shrivastava serve as directors at the Company.
Company Details
-
Location
Jabalpur, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110MP2014PTC032943
-
Company No.
032943
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Jul 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Neenv Ent And Cancer Hospitals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Adgaonkar
|
Director | 21-Jul-2014 | Current |
|
Akhil Shrivastava
|
Director | 12-Dec-2018 | Current |
Financial Performance of Neenv Ent And Cancer Hospitals.
Neenv Ent And Cancer Hospitals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 38.01% increase. The company also saw a slight improvement in profitability, with a 4.32% increase in profit. The company's net worth Soared by an impressive increase of 29.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neenv Ent And Cancer Hospitals?
In 2020, Neenv Ent And Cancer Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹17.85 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.26 Cr
- Central Bank Of India : 0.53 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2021 | Others | ₹1.26 Cr | Open |
| 27 May 2015 | Central Bank Of India | ₹5.25 M | Open |
How Many Employees Work at Neenv Ent And Cancer Hospitals?
Unlock and access historical data on people associated with Neenv Ent And Cancer Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neenv Ent And Cancer Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neenv Ent And Cancer Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
